papaya

Papaya (Carica papaya L.): A Comprehensive Reference

1. Identity

Botanical and Chemical Classification

Carica papaya (melon tree) belongs to the family Caricaceae, order Violales, and produces large, juicy, and tasty fruits known as papayas. The fruit is widely known under numerous regional synonyms, including papaya (Europe and Spain), pawpaw (Australia), mamão (Brazil), fruit de bomba (Cuba), tree melon (Europe), and lechosa (Venezuela and other Spanish-speaking regions). The accepted binomial scientific name is Carica papaya Linn., with the species epithet referring to the traditional genus Carica.

Natural Source and Distribution

The papaya plant originated in Central America and is now grown in tropical areas worldwide, most particularly in Africa and Asia. Originally native to tropical regions, large-scale commercial cultivation is now found in Sri Lanka, Pakistan, India, Australia, East Africa, and Brazil, while Mexico and Central America maintain substantial plantations. The Spanish chronicler Oviedo first formally described Carica papaya in 1526 A.D.

Carica papaya is a fast-growing, soft-wooded, herbaceous plant reaching 3–10 m in height. Its leaves are large (30–60 cm long), yellow-green to dark-green in colour, palmately lobed, arranged spirally, and clustered at the crown.

Plant Parts Used and Common Preparations

In traditional medicine, different parts of C. papaya L. — including leaves, stem, roots, fruits, and seeds — are utilized to treat various diseases. As a dietary supplement, papaya is found in several forms:

• Fresh ripe fruit flesh — consumed directly for nutritional and digestive purposes.
• Fresh or dried green (unripe) fruit — the primary source of the latex-derived enzyme papain.
• Papaya enzyme (papain) supplements — available as fruit mash/puree, powder, capsules, chewable tablets, and lozenges, and also formulated into creams, gels, and wound dressings.
• Leaf extract and leaf preparations — standardized aqueous extracts, juices, and decoctions used particularly for dengue-associated thrombocytopenia.
• Fermented papaya preparation (FPP) — a product of Carica papaya Linn. fermentation with yeast, marketed as a nutraceutical supplement.
• Seeds — dried and ground, used as a spice with a pepper-like flavor.

2. Traditional and Historical Use

Mesoamerican and Indigenous American Traditions

The first written reports on possible healing effects of papaya go back to the Spaniard Oviedo in 1526. In traditional medical cultures, papayas — including the peel, fruit pulp, and seeds, and rarely leaves and latex — are primarily used to treat asthma, parasitoses, wound healing disorders, and gastrointestinal problems such as diarrhoea or constipation. Their constituents were understood to stimulate and regulate digestive activity, mitigate gastric hyperacidity, reduce excessive flatulence, and promote protein cleavage.

South and Southeast Asian Traditions

In traditional medicine, Carica papaya leaves have been used for treatment of asthma, colic, fever, beriberi (thiamine deficiency), and as an abortifacient in India, and for malaria and dengue fever in Sri Lanka, Pakistan, and Malaysia. In South-East Asia, both ripe and green fruit are used, and additionally leaves are popularly consumed either raw in salad or cooked as a green vegetable.

Aboriginal Australian Tradition

Carica papaya leaf decoction has been used as an Australian Aboriginal remedy, widely employed for its claimed healing capabilities against cancer, with numerous anecdotal reports. The traditional Aboriginal preparation involves a prolonged heating process to produce the leaf decoction, which alters the phytochemical profile compared to cold-pressed leaf juice, as has been documented in analytical studies.

African and Broader Tropical Use

C. papaya has a wide range of purported medicinal properties across traditional systems of medicine, including antiseptic, antimicrobial, antiparasitic, anti-inflammatory, antihypertensive, diuretic, antihyperlipidemic, antidiabetic, and contraceptive activity. Seeds have historically been employed as an anthelmintic (anti-worm) agent in various African and Asian contexts. Traditionally, the leaves of C. papaya, in decoction or infusion form, are consumed orally to reduce blood pressure and sugar levels.

Vietnam and Other Countries

The use of papaya for cancer treatment has been documented in Vietnam and Australia. These traditional cancer-related uses are anecdotal and have served as the basis for modern scientific inquiry into the plant's potential anticancer constituents, though clinical evidence remains very preliminary.

3. Key Constituents and Active Compounds

Overview of Phytochemical Classes

Constituents of the papaya plant belong to different chemical classes that include alkaloids, flavonoids, terpenoids, saponins, steroids, tannins, vitamins, quinones, minerals, and others. Papaya is abundant in vitamins A, C, and E; minerals; enzymes; and phytochemicals such as flavonoids, phenolic acids, carotenoids, and alkaloids, all of which contribute to its antioxidant, anti-aging, anti-inflammatory, and anticancer effects.

Enzymes

Papain is a cysteine protease enzyme found primarily in the milky latex of raw papaya (Carica papaya). As a proteolytic enzyme, it breaks peptide bonds in proteins, effectively helping the body digest dietary protein more efficiently. Six enzymes have been isolated from papaya: papain, chymopapain A and B, lysozyme, lipase, and glutamine cyclopherase. Chymopapain, like papain, is a cysteine protease with comparable proteolytic activity but a distinct substrate specificity. Papain has an optimal pH range in slightly acidic to neutral conditions and is heat-stable up to moderate temperatures.

Carotenoids

Beta-carotene, a precursor of vitamin A, promotes vision, immune function, and skin health. Lycopene, known for its potent antioxidant activity, is associated with a reduced risk of prostate cancer and cardiovascular diseases. Beta-cryptoxanthin contributes to respiratory health and enhances overall antioxidant capacity. Papaya is also rich in carotenoids like lutein, zeaxanthin, and xanthophyll, which play a crucial role in maintaining eye health. Lycopene imparts a bright red color to food and is among the main carotenoids in papaya (alongside tomatoes, watermelon, and guava).

Alkaloids

The fruit of Carica papaya L. contains alkaloids including carpaine and pseudocarpaine, in addition to the proteolytic enzymes papain and chymopapain. Carpaine, a macrocyclic dilactone piperidine alkaloid, is found predominantly in the leaves and has been investigated for cardiovascular and antitumor properties in preclinical models. Phytochemical investigation of the hydromethanolic extract of Carica papaya Linn. leaves resulted in the isolation and characterization of multiple compounds, including carpaine, methyl gallate, loliolide, rutin, clitorin, kaempferol-3-O-neohesperidoside, isoquercetin, nicotiflorin, and isorhamnetin-3-O-β-d-glucopyranoside.

Phenolic Compounds and Flavonoids

The leaves contain alkaloids as well as quercetin and kaempferol as the main phenolic compounds. Phenolic compounds present in different plant extracts include 5-hydroxy feruloyl quinic acid, acetyl p-coumaryl quinic acid, quercetin-3-O-rhamnoside, syringic acid hexoside, 5-hydroxy caffeic quinic acid, peonidin-3-O-glucoside, sinapic acid-O-hexoside, cyanidin-3-O-glucose, and methyl feruloyl glycoside, as identified by LC-MS technique.

Vitamins and Minerals

Papaya is a very good source of pectin, vitamins A, B, and C, essential fatty acids, bioflavonoids, potassium, calcium, magnesium, phosphatides, peptides, and amino acids such as arginine. The orange or red flesh of ripe papaya is an excellent source of pro-vitamin A and ascorbic acid (vitamin C).

Seeds

The seeds are a rich source of proteins (27.8% undefatted, 44.4% defatted) and crude fiber (22.6% undefatted, 31.8% defatted). Seeds also contain benzyl isothiocyanate, a glucosinolate hydrolysis product implicated in the observed antiparasitic and antimicrobial activity of seed preparations.

4. Established and Proposed Mechanisms of Action

Proteolytic Activity (Papain and Chymopapain)

Papain is a proteolytic enzyme extracted from the raw fruit of the papaya plant. Proteolytic enzymes help break proteins down into smaller protein fragments called peptides and amino acids. Because papain acts directly on proteins, it can help break down food, soften scarred or damaged tissue, and influence inflammation pathways in the body. Papain is used as a therapeutic alternative for wound healing due to its debridement action on devitalized or necrotic tissues.

Antioxidant Mechanisms

Fermented papaya preparation (FPP), produced by fermentation of Carica papaya Linn. by using yeast, is a food supplement that possesses beneficial and potent antioxidant properties and exhibits anti-inflammatory, antioxidant, and immunostimulatory action as well as induction of antioxidant enzymes. FPP has been shown to modulate H₂O₂-induced ERK, Akt, and p38 activation, with reduction of p38 phosphorylation induced by H₂O₂, and to reduce the extent of H₂O₂-induced DNA damage. Carotenoids from the fruit (lycopene, beta-carotene) are exceptionally efficient physical and chemical quenchers of singlet oxygen and other reactive oxygen species.

Anti-inflammatory Mechanisms

Studies have validated that papaya possesses several pharmacological activities, including antioxidant, antiulcer, antibacterial, wound-healing, anti-inflammatory, and anti-sickling effects. In preclinical models, oral administration of papain has been shown to reduce high-fat diet-induced weight of the body, liver, and adipose tissues in mice, and to reduce hepatic lipid accumulation and adipocyte size. The anti-inflammatory action of papain is proposed to involve its proteolytic degradation of damaged proteins and extracellular matrix fragments in injured tissue.

Platelet-Modulating Mechanisms (Leaf Extract)

The flavonoids of C. papaya leaf extract have been shown to inhibit a protease involved in viral assembly. Recent evidence demonstrates that dengue-associated thrombocytopenia is driven by both impaired platelet production and accelerated peripheral destruction, and proposed mechanisms for papaya leaf extract include upregulation of thrombopoiesis-related pathways and immunomodulation of platelet destruction.

5. Scientific Evidence by Area of Use

5.1 Gastrointestinal Health and Digestive Disorders

Clinical evidence (moderate quality, limited scale): The most directly relevant human trial for papaya as a digestive aid is a double-blind, placebo-controlled study of the preparation Caricol® (a proprietary standardized green papaya preparation). Papaya (Carica papaya L.) is used as a natural remedy in abnormal digestion in tropical and industrialized countries. Despite this wide distribution, little evidence had been produced regarding its physiological effect in humans. Former clinical observations had revealed positive effects for patients with constipation, heartburn, and symptoms of IBS after eating papaya preparations. In line with these observations, the clinical effects of Caricol® were studied in a double-blind, placebo-controlled study design in volunteers with chronic indigestions and dysfunctions of the gastrointestinal tract.

In the treatment group, statistically significant improvements were observed in constipation and bloating. Analysis of heartburn fell short of significant improvement because of the small number of included cases with this symptom (N=13, p=0.114). None of the significant benefits were observed after the washout phase. The investigators concluded that the papaya preparation Caricol® contributes to the maintenance of digestive tract physiology and ameliorates various functional disturbances, including symptoms of IBS.

Limitations: The trial was conducted with a single proprietary preparation; results may not generalize to other papaya supplements or fresh fruit. The study population was modest in size and restricted to volunteers with chronic but non-severe gastrointestinal complaints.

5.2 Dengue Fever and Thrombocytopenia

Clinical evidence (multiple RCTs; systematic review available; evidence promising but still insufficient for firm recommendation): Carica papaya (CP) extract has become popular as an unlicensed herbal remedy purported to hasten recovery in dengue infection, mostly based on observations that it may increase platelet counts.

A double-blind, placebo-controlled, randomized, multi-centric prospective study evaluated the efficacy and safety of Carica papaya leaf extract (CPLE) as empirical therapy for thrombocytopenia associated with dengue fever. The results indicate that CPLE had a significant increase (p<0.01) in the platelet count over the therapy duration in dengue fever patients, confirming that CPLE accelerates the increase in platelet count compared to the control group. There were few adverse events related to GI disturbance (nausea and vomiting), which were similar in both groups; the study concluded that CPLE does significantly increase platelet count in patients with dengue-associated thrombocytopenia with fewer side effects and good tolerability.

A systematic review and meta-analysis published in PubMed (2019) analyzed prospective controlled clinical trials on the efficacy and safety of CP extract. No evidence was available regarding other clinical outcomes, and the clinical value of improvement in platelet count or early discharge was considered unclear in the absence of more robust indicators of favourable clinical outcome.

An earlier systematic review concluded that C. papaya leaf extract has a definitive role in improving the platelet count in patients with dengue, but there is a need for high-quality evidence in the form of large clinical trials before a decision related to the use of such extract is made. Majority of the parameters through which bias can be evaluated were not reported in these clinical trials; in the absence of this information, the authenticity of the results cannot be considered free of bias.

CPLE has emerged as an off-label treatment option, showing promising results in increasing platelet counts and reducing hospital stays; however, a critical assessment of existing research reveals methodological flaws, hindering specific recommendations. Evidence is further limited by small trials and lack of standardized dosing, and there is an urgent need for large RCTs to confirm safety and efficacy.

5.3 Wound Healing and Topical Debridement

Clinical evidence (moderate; human studies exist for topical papain-urea formulations): While there are limited data to support most traditional papaya uses, there is some clinical evidence for use in treating decubitus ulcers and wounds.

In multiple clinical studies with over 350 people and 30 children, papaya enzyme applied to the skin sped up the healing of skin ulcers or burns, reduced wound size, removed damaged tissue, accelerated wound closure, and shortened hospital stay. It performed better than collagenase, hydrogen peroxide dressing, or placebo. Historically, papain-urea ointments were used to remove necrotic tissue from burns, pressure sores, and ulcers. A clinical study in patients with large burn wounds found that papain-urea debridement was effective in removing dead tissue and generally safe when used properly. Regulatory policies have since tightened in some countries due to concerns about unapproved topical papain formulations and rare severe reactions; enzymatic debridement using papain is now typically restricted to specific products and specialist settings.

Limitations: Much of the wound-healing evidence predates modern regulatory standards for trial design. High doses of papain can induce potential skin irritation and side effects.

5.4 Oxidative Stress, Aging, and Neurodegenerative Risk Factors

Clinical evidence (small RCTs; mechanistic human studies; promising but preliminary): Fermented papaya preparation (FPP) is a nutraceutical supplement with reported favorable effects on immunological, hematological, inflammatory, and oxidative stress parameters in chronic and degenerative diseases.

One placebo-controlled study assessed the effects of FPP on 40 participants (28 Alzheimer's disease patients and 12 controls), measuring urinary 8-OHdG as an oxidative stress marker. Twenty AD patients were supplemented with FPP (Immunage, 4.5 g/day) for 6 months, while controls did not receive any treatment. Although the role of oxidative stress in aging and neurodegenerative diseases is broadly accepted, the value of antioxidant strategies remains debatable. Well-defined long-term trials are still needed to assess the efficacy of antioxidant strategies or antioxidant-rich nutritional intervention.

A 2-year double-blind RCT examined FPP in middle-aged subjects with clustered neurodegenerative disease risk factors. The study population consisted of 90 patients aged 45–65 years old with impending metabolic syndrome; one group received FPP 4.5 g twice a day (the most common dosage used in prior clinical studies) while the other received an oral antioxidant cocktail.

A randomized controlled trial in a Mauritian neo-diabetic population examined short-term FPP supplementation. A randomized controlled clinical trial was conducted to determine the effect of short-term supplementation of FPP® (6 g/day for 14 weeks) on biomarkers of diabetes and antioxidant status. Supplementation could improve the general health status of several organs targeted by oxidative stress during diabetes; C-reactive protein levels significantly decreased (p=0.018), and LDL/HDL ratio was considerably changed (p=0.042).

Limitations: The FPP literature is concentrated on a single commercial product and relatively small study populations. Long-term efficacy data are sparse, and the contribution of fermentation-generated compounds versus native papaya compounds is not fully characterized.

5.5 Antidiabetic Effects

Evidence: mostly preclinical, with limited clinical data: The fruit demonstrates significant activity against diabetes and obesity in preclinical research. Fermented papaya may decrease blood sugar in people with type 2 diabetes; since diabetes medications are also used to lower blood sugar, taking fermented papaya along with diabetes medications might cause blood sugar to go too low. Human clinical evidence beyond the FPP/diabetes biomarker trials described above is limited and primarily observational or derived from small controlled studies.

5.6 Cardiovascular Health

Evidence: carotenoid-level epidemiology; no papaya-specific RCTs: Papaya's cardiovascular relevance is primarily inferred from its rich carotenoid content, particularly lycopene. Lycopene is a lipophilic, unsaturated carotenoid found in papaya (among other red fruits). Its main activity profile includes antiatherosclerotic, antioxidant, anti-inflammatory, antihypertensive, antiplatelet, anti-apoptotic, and protective endothelial effects, and the ability to improve the metabolic profile and reduce arterial stiffness. However, although the results of observational studies suggest that diets high in carotenoid-rich fruits and vegetables are associated with reduced risks of cardiovascular disease and some cancers, high-dose β-carotene supplements did not reduce the risk of cardiovascular disease or cancer in large randomized controlled trials. No dedicated RCTs have examined whole papaya fruit or papaya extract specifically for cardiovascular endpoints.

5.7 Anticancer Properties

Evidence: predominantly in-vitro and animal; no clinical evidence in humans: Both in vitro and in vivo studies have highlighted the therapeutic potential of papaya-derived compounds in various health conditions, including cancer. Lycopene, for example, is associated with a reduced risk of prostate cancer and cardiovascular diseases based on epidemiological data, though this association is derived from dietary patterns broadly, not from papaya supplementation specifically. Studies on carpaine and quercetin from papaya leaves show cytotoxic activity against cancer cell lines in vitro, but translation to clinical evidence is absent.

5.8 Antiparasitic and Anthelmintic Effects

There is some clinical evidence for use of papaya in treating intestinal worms. Preparations from papaya seeds, latex, and unripe fruit have been used in tropical medicine for intestinal parasites. Benzyl isothiocyanate from seeds has demonstrated anthelmintic activity in animal models and small human trials, though standardized, large-scale controlled human evidence remains limited.

6. Body Systems and Health Areas Associated with Papaya

• Gastrointestinal system: Papain's proteolytic action, constipation, heartburn, bloating, IBS-type symptoms, gastritis, wound debridement in gastric ulcers (preclinical).
• Immune system and haematology: Platelet modulation (dengue/CPLE studies), immunostimulatory effects of FPP, antiviral properties (flavonoids inhibiting dengue protease).
• Integumentary system (skin/wound care): Topical debridement of necrotic tissue in burns, pressure sores, and diabetic ulcers via papain-urea formulations.
• Cardiovascular system: Lycopene-associated antioxidant, antiatherosclerotic, and antihypertensive potential (epidemiological and mechanistic data; no papaya-specific RCTs).
• Oxidative stress and aging: FPP-related reduction of oxidative biomarkers (8-OHdG, CRP, oxidized LDL); studied in metabolic syndrome, diabetes, and Alzheimer's disease contexts.
• Endocrine/metabolic system: Blood sugar modulation (FPP, fermented preparations); potential antidiabetic effects primarily from in vitro/animal studies and limited RCTs.
• Ocular health: Lutein, zeaxanthin, and beta-carotene content relevant to macular health and vision.
• Anti-infectious (parasitic) use: Traditional anthelmintic and antiparasitic use supported by limited clinical data for seed preparations.

7. Dosage Forms and Dosages Reported in Studies

The following dosages are reported in the cited scientific literature only. No dosage constitutes a recommended therapeutic amount.

• Fermented papaya preparation (FPP / Immunage): 4.5 g/day was used in a 6-month study of Alzheimer's disease patients.
• FPP in metabolic syndrome RCT: 4.5 g twice a day (9 g/day total) described as the most common dosage used in prior clinical studies.
• FPP in neo-diabetic population RCT: 6 g/day for 14 weeks.
• Caricol® (green papaya preparation) for gastrointestinal disorders: Used in a double-blind, placebo-controlled study; the specific milligram dosage of Caricol® in that trial is not provided in the accessible abstracts.
• Carica papaya leaf extract (CPLE) for dengue: Evidence is limited by small trials and lack of standardized dosing; exact dosages differed across trials and no consensus standardized dose has been established.
• Oral papain enzyme supplements are available as fruit mash/puree, powder, capsules, chewable tablets, and lozenges, but no standardized oral therapeutic dose for papain has been established or approved by major regulatory agencies.

8. Safety Considerations and Drug Interactions

General Safety Profile

Consumption of C. papaya leaf in adults is generally safe for short-term use, though caution is warranted in pregnancy and in people with liver impairment. Minor gastrointestinal side effects (nausea, vomiting) are most commonly reported. There are concerns about hepatotoxicity and reproductive toxicity in long-term use, supported by animal studies.

Pregnancy

Unripe papaya fruit is considered possibly unsafe when taken by mouth during pregnancy. There is evidence that unprocessed papain, one of the chemicals found in unripe papaya fruit, might poison the fetus or cause birth defects. This concern relates specifically to medicinal or supplemental doses of unripe papaya or papain, not to dietary consumption of ripe fruit flesh in normal food quantities.

Allergy and Latex Cross-Reactivity

Individuals with a latex allergy should use caution with papaya or products containing papaya, as cross-reactivity may exist. Those allergic to papain specifically should avoid unripe papaya. High doses of papain can induce potential skin irritation and side effects.

Interaction with Anticoagulants (Warfarin)

One case report suggests that papain, a digestive enzyme found in papaya extract (Carica papaya), might add to warfarin's blood-thinning effect. Papaya might increase the effects of warfarin and increase the chances of bruising and bleeding; regular monitoring of blood clotting is advised, and the dose of warfarin may need to be adjusted. This interaction is classified as requiring caution, though it is based on limited case report data.

Interaction with Antidiabetic Medications

Fermented papaya may decrease blood sugar in people with type 2 diabetes. Since diabetes medications are also used to lower blood sugar, taking fermented papaya along with diabetes medications might cause blood sugar to go too low; blood sugar should be monitored closely.

Interactions with Other Medications

Unfavourable herb-drug interactions with metformin, glimepiride, digoxin, ciprofloxacin, and artemisinin have been documented for C. papaya leaf. It has potential herb-drug interactions with oral hypoglycaemic agents, p-glycoprotein substrates, and antibiotics with cation-chelating properties. Taking papaya extract by mouth along with amiodarone might increase the amount of amiodarone in the body, potentially increasing both its effects and adverse effects. Eating large amounts of papaya might reduce the effects of levothyroxine.

Perioperative Considerations

Fermented papaya can lower blood sugar, which might affect blood sugar control during and after surgery; discontinuation is suggested at least 2 weeks before surgery.

FDA Regulatory Status of Topical Papain

Regulatory policies have tightened in some countries due to concerns about unapproved topical papain formulations and rare severe reactions. Today, enzymatic debridement using papain is typically restricted to specific products and specialist settings, if used at all. Papaya enzyme supplements have not been approved by the FDA for medical use due to the lack of solid clinical research.

References

• Kaur et al. "Ethnomedicinal Uses, Phytochemistry and Pharmacology of Carica papaya Plant: A Compendious Review." Mini-Reviews in Organic Chemistry (2019). Bentham Science.
• Aja et al. "Ethnomedicinal uses, nutritional composition, phytochemistry and potential health benefits of Carica papaya." ScienceDirect (2023).
• Springer Nature. "Bioactive constituents from Carica papaya fruit: implications for drug discovery and pharmacological applications." Applied Biological Chemistry (2024).
• PubMed. "Carica papaya in health and disease: a review of its bioactive compounds." PubMed (2025).
• PMC. "Chemical constituents from Carica papaya Linn. leaves as potential cytotoxic, EGFRwt and aromatase (CYP19A) inhibitors." PMC (2022).
• Nguyen et al. "Phytochemicals of papaya and its traditional health and culinary uses – A review." ScienceDirect (2015).
• PMC. "Traditional Aboriginal Preparation Alters the Chemical Profile of Carica papaya Leaves and Impacts on Cytotoxicity towards Human Squamous Cell Carcinoma." PLOS ONE (2016).
• Drugs.com Natural Products. "Papaya Uses, Benefits & Dosage."
• PubMed. Kasture et al. "A Multi-centric, Double-blind, Placebo-controlled, Randomized, Prospective Study to Evaluate the Efficacy and Safety of Carica papaya Leaf Extract as Empirical Therapy for Thrombocytopenia associated with Dengue Fever." J Assoc Physicians India (2016).
• PubMed. Rajapakse et al. "Carica papaya extract in dengue: a systematic review and meta-analysis." BMC Complementary Medicine and Therapies (2019).
• PMC. "Efficacy and safety of Carica papaya leaf extract in dengue: A systematic review and meta-analysis." PMC (2016).
• PubMed. "Exploring the potential of Carica Papaya Leaf Extract: a perspective on its effectiveness in ameliorating thrombocytopenia in dengue patients." PubMed (2025).
• ScienceDirect. "Papaya leaf extract: A potential ally against dengue-induced thrombocytopenia in low-income countries." ScienceDirect (2025).
• PubMed. Muss C, Mosgoeller W, Endler T. "Papaya preparation (Caricol®) in digestive disorders." Neuroendocrinology Letters (2013).
• PMC. "Oxidative Stress in Patients with Alzheimer's Disease: Effect of Extracts of Fermented Papaya Powder." PMC (2015).
• PMC. "A 2-year Double-Blind RCT Follow-up Study with Fermented Papaya Preparation (FPP) Modulating Key Markers in Middle-Age Subjects with Clustered Neurodegenerative Disease-Risk Factors." PMC (2019).
• PubMed. "Effects of a short term supplementation of a fermented papaya preparation on biomarkers of diabetes mellitus in a randomized Mauritian population." PubMed (2012).
• PubMed. "Applications and bioefficacy of the functional food supplement fermented papaya preparation." PubMed (2010).
• PMC. "Benefits of Fermented Papaya in Human Health." PMC (2022).
• PMC. "Papain Ameliorates Lipid Accumulation and Inflammation in High-Fat Diet-Induced Obesity Mice and 3T3-L1 Adipocytes via AMPK Activation." PMC (2021).
• PMC. "Immobilization of Papain in Chitosan Membranes as a Potential Alternative for Skin Wounds." PMC (2023).
• PMC. "Carica papaya L. Leaf: A Systematic Scoping Review on Biological Safety and Herb-Drug Interactions." PMC (2021).
• PMC. "Lycopene and Vascular Health." PMC (2018).
• PMC. "Chemistry, Occurrence, Properties, Applications, and Encapsulation of Carotenoids—A Review." PMC (2023).
• PMC. "Nutritional Benefits of Lycopene and Beta-Carotene: A Comprehensive Overview." PMC (2024).
• Linus Pauling Institute, Oregon State University. "Carotenoids." Micronutrient Information Center (2026).
• WebMD Natural Medicines. "Papaya: Overview, Uses, Side Effects, Precautions, Interactions, Dosing."
• EBSCO Research Starters. "Warfarin (drug interactions)."